首页> 外文期刊>Cardiovascular therapeutics >Preoperative statin therapy decreases risk of postoperative renal insufficiency.
【24h】

Preoperative statin therapy decreases risk of postoperative renal insufficiency.

机译:术前他汀类药物治疗可降低术后肾功能不全的风险。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

INTRODUCTION: Although current guidelines recommend withholding statins in perioperative patients, little information is available on whether perioperative statin use increases risk for postoperative renal failure. AIMS: We examined the relation between preoperative statin therapy and postoperative risk for renal insufficiency in patients undergoing cardiac surgery. METHODS: Retrospective cohort review from the Texas Heart Institute research database was performed. Patients were divided into two groups: those who received preoperative statins and those who did not. Primary outcome was the development of postoperative renal insufficiency (requiring dialysis or not). Outcomes were assessed in the entire cohort and in subgroups undergoing isolated coronary artery bypass grafting (CABG), isolated valve surgery, or combined CABG and valve surgery. RESULTS: Of 3001 patients, 56% received preoperative statins. In multivariate logistic regression analysis, preoperative statins were associated with significant reductions in risk for postoperative renal insufficiency in the entire cohort (odds ratio [OR]= 0.60, 95% confidence interval [CI] 0.38-0.95) and in patients undergoing isolated CABG (OR = 0.34, 95% CI 0.17-0.68). In patients undergoing isolated valve surgery (OR = 1.35, 95% CI 0.61-2.96) or combined CABG and valve surgery (OR = 1.39, 95% CI 0.48-3.99), preoperative statins were not associated with decreased incidence of postoperative renal insufficiency. Age >65 years, preoperative renal insufficiency, history of congestive heart failure, preoperative intra-aortic balloon pump insertion, and total cardiopulmonary bypass time >80 min were also independent predictors associated with increased risk for postoperative renal insufficiency. CONCLUSIONS: Preoperative statin therapy was associated with decreased incidence of postoperative renal insufficiency in patients undergoing cardiac surgeries, particularly in patients undergoing isolated CABG.
机译:简介:尽管目前的指南建议围手术期患者停用他汀类药物,但关于围手术期使用他汀类药物是否会增加术后肾衰竭的风险,目前尚无足够的信息。目的:我们检查了接受心脏手术患者的他汀类药物治疗与术前肾功能不全风险之间的关系。方法:进行了德克萨斯州心脏研究所研究数据库的回顾性队列研究。患者分为两组:术前接受他汀类药物和未接受他汀类药物的患者。主要结局是术后肾功能不全的发展(是否需要透析)。在整个队列和接受隔离冠状动脉旁路移植术(CABG),隔离瓣膜手术或CABG和瓣膜手术联合治疗的亚组中评估结果。结果:3001例患者中,有56%接受了术前他汀类药物治疗。在多因素Logistic回归分析中,术前他汀类药物与整个队列(赔率[OR] = 0.60,95%置信区间[CI] 0.38-0.95)和接受单独CABG的患者(肾病)的术后肾功能不全风险显着降低有关OR = 0.34,95%CI 0.17-0.68)。在接受单纯瓣膜手术(OR = 1.35,95%CI 0.61-2.96)或CABG联合瓣膜手术(OR = 1.39,95%CI 0.48-3.99)的患者中,术前他汀类药物与术后肾功能不全发生率降低无关。年龄> 65岁,术前肾功能不全,充血性心力衰竭的病史,术前主动脉内球囊泵插入术以及总体外循环时间> 80分钟也是与术后肾功能不全风险增加相关的独立预测因素。结论:心脏手术患者,特别是单纯CABG患者,术前他汀类药物治疗与术后肾功能不全发生率降低相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号